baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Pacira BioSciences Inc/ US6951271005 /

2024-09-20 10:00:00 PM	Chg. -0.1600	Volume	Bid12:33:51 AM	Ask12:33:51 AM	High	Low
14.5300USD	-1.09%	4.3 mill. Turnover: 55.02 mill.	14.7300Bid Size: 200	16.8300Ask Size: 100	15.1500	14.4800

GlobeNewswire 08-09 Pacira BioSciences Comments on Ruling on EXPAREL Patent Litigation from U.S. District Court for the ...

GlobeNewswire 07-30 Pacira BioSciences Reports Second Quarter 2024 Financial Results

GlobeNewswire 07-23 Pacira to Report Second Quarter 2024 Financial Results on Tuesday July 30, 2024

GlobeNewswire 07-10 Centers for Medicare and Medicaid Propose New Reimbursement for EXPAREL in All Outpatient Surgical E...

GlobeNewswire 05-30 Pacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare Conferenc...

GlobeNewswire 05-10 Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Co...

GlobeNewswire 05-08 Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of...

GlobeNewswire 05-07 Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Rep...

GlobeNewswire 05-07 Pacira BioSciences to Participate in Fireside Chat at the 2024 RBC Capital Markets Global Healthcare...

GlobeNewswire 04-30 Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024

GlobeNewswire 04-02 Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Con...

GlobeNewswire 03-28 Endonovo Closes Asset Purchase Agreement for a Minimum of $50M With SofPulse, Inc

GlobeNewswire 03-13 Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designati...

GlobeNewswire 03-06 Pacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare Con...

GlobeNewswire 02-29 Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results

GlobeNewswire 02-22 Pacira to Report 2023 Financial Results on Thursday February 29, 2024

GlobeNewswire 02-15 Pacira Announces Publication of Pivotal Study of EXPAREL as a Sciatic Nerve Block in the Popliteal F...

GlobeNewswire 02-07 Pacira BioSciences Awarded Brand Pharmaceuticals Agreement With Premier, Inc.

GlobeNewswire 01-04 Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues

GlobeNewswire 01-03 Pacira BioSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire 2023-12-21 Pacira Appoints Frank D. Lee as Chief Executive Officer

GlobeNewswire 2023-11-10 Pacira Announces FDA Approval of Expanded EXPAREL Label to Include Two Additional Nerve Block Indica...

GlobeNewswire 2023-11-07 Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in November

GlobeNewswire 2023-11-02 Pacira BioSciences Reports Third Quarter 2023 Financial Results

GlobeNewswire 2023-10-26 Pacira to Report Third Quarter 2023 Financial Results on Thursday November 2, 2023

Pacira BioSciences Inc/ US6951271005 /

If you wish to receive reply to your feedback, please provide your email address.